Table I.
Comparison between study and control group
| Variable | Baseline | After 6-month follow-up | |||
|---|---|---|---|---|---|
| Study group (N = 95) | Control group (N = 31) | P-value | Study group (N = 95) | Control group (N = 31) | |
| Age [years] | 53.1 (13.0) | 53.0 (13.2) | 0.97 | 53.1 (13.0) | 53.0 (13.2) |
| Male gender (%) | 51 (53.6) | 16 (51.6) | 0.94 | 51 (53.6) | 16 (51.6) |
| Body weight [kg] | 80.3 (14.8) | 71.5 (10.9) | 0.003 | 79.7 (14.2) | 71.5 (10.9) |
| Height [cm] | 169.7 (8.4) | 169.9 (8.8) | 0.90 | ||
| Obese patients, n (%) | 12 (12.6) | 2 (6.4) | 0.006 | 12 (12.6) | 2 (6.4) |
| Patients with diabetes type 2, n (%) | 6 (6.3) | 2 (6.4) | 0.87 | 6 (6.3) | 2 (6.4) |
| Smokers, n (%) | 12 (12.6) | 4 (12.9) | 0.56 | 12 (12.6) | 4 (12.9) |
| HR [bpm] | 73.1 (10.8) | 72.1 (7.4) | 0.62 | 69.6 (12.3) | 70.2 (7.7) |
| SBP [mm Hg] | 153.5 (19.4) | 131.1 (14.2) | < 0.0001 | 136.9 (15.4) | 129.4 (11.0) |
| DBP [mm Hg] | 94.2 (10.3) | 82.5 (8.0) | < 0.0001 | 85.1 (9.3) | 80.8 (8.5) |
| PWV [m/s] | 10.6 (1.6) | 9.8 (1.2) | 0.011 | 10.0 (1.7) | 9.7 (1.4) |
| Creatinine [µmol/l] | 67.6 (13.0) | 65.4 (11.6) | 0.38 | 65.8 (16.1) | 67.8 (11.5) |
| Glucose [mmol/l] | 5.1 (0.9) | 4.9 (0.9) | 0.65 | 5.0 (0.7) | 5.0 (0.9) |
| Total cholesterol [mmol/l] | 5.4 (0.9) | 4.7 (0.9) | 0.001 | 5.12 (0.6) | 4.7 (0.8) |
| Triglycerides [mmol/l] | 1.5 (0.7) | 1.3 (0.7) | 0.18 | 1.66 (0.7) | 1.46 (0.6) |
| HDL [mmol/l] | 1.4 (0.4) | 1.5 (0.5) | 0.21 | 1.41 (0.4) | 1.58 (0.4) |
| LDL [mmol/l] | 3.3 (0.8) | 2.6 (0.9) | 0.001 | 2.97 (0.6) | 2.59 (0.7) |
Data are given as mean (SD) or number (n) (percentage %); HR – heart rate, SBP – office systolic blood pressure, DBP – office diastolic blood pressure, PWV – carotid-femoral pulse wave velocity, HDL – high-density lipoprotein, LDL – low-density lipoprotein. P-value for the comparison between study and control group at the baseline. The differences (p-values) between study and control group after a 6-month period did not differ from baseline p-values.